However, DAF was higher in PCOS-nonGH than PCOS-GH and, whilst they were not significantly different, the decay accelerating factor (DAF/CD55) was significantly decreased versus controls in PCOS-GH and PCOS-SGH, but not in PCOS-nonGH. This evidence concerns the gene CD55 and polycystic ovary syndrome.